Deepali Wanode

Deepali Wanode

Auto-generated profile, based on publicly available information

Deepali Wanode

Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur 440033, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
DWDeepali M. Wanode
Deepali M. Wanode
PKPramod B. Khedekar
Pramod B. Khedekar
SCSomdatta Y. Chaudhari
Somdatta Y. Chaudhari

13 September 2025 in Medicine in Drug Discovery
Verified
Journal Article
Open access
DWDeepali M. Wanode
Deepali M. Wanode
PKPramod B. Khedekar
Pramod B. Khedekar

1 April 2026 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
DWDeepali Wanode
Deepali Wanode
DNDeweshri Nandurkar
Deweshri Nandurkar
MAMegha Ambatkar
Megha Ambatkar
NRNilesh Ramesh Rarokar
Nilesh Ramesh Rarokar
PKPramod Khedekar
Pramod Khedekar
The field of cancer research has witnessed a surge in the exploration of novel therapeutic agents, with pyrazole derivatives emerging as promising candidates in the quest for effective anticancer treatments. This comprehensive review provides an in-depth analysis of the research landscape surrounding pyrazole derivatives as potential anticancer agents over the period from 2012 to 2024. Many synthetic pyrazole derivatives have been approved by the FDA and used as chemotherapeutic medicines, and some are under clinical trials, also reported in this article. The review aims to serve as a valuable resource for researchers, guiding future investigations and fostering the development of innovative pyrazole-based anticancer therapeutics.

1 January 2025 in Journal of Applied Pharmaceutical Science
Verified
Journal Article
Open access
DWDeepali M. Wanode
Deepali M. Wanode
KBKumud P. Bhendarkar
Kumud P. Bhendarkar
PKPramod B. Khedekar
Pramod B. Khedekar
Angiogenesis, the formation of new blood vessels, plays an important role in tumor growth and metastasis. Vascular endothelial growth factor receptor-2 (VEGFR-2) is a key regulator of this process and a crucial target for anti-angiogenic cancer therapies. In this work, a series of pyrazole–pyrazoline derivatives were designed by incorporating various heterocyclic moieties, such as thiazole, benzothiazole, pyridine, furan, thiophene, and pyrrole, to improve VEGFR-2 inhibition. Using an in silico approach, molecular docking studies with AutoDock Vina revealed strong binding interactions, particularly hydrophobic and hydrogen bonding, with amino acid residues of the VEGFR-2 protein. The compounds were tested for pharmacokinetic properties and drug-likeness using SwissADME, and their absorption, distribution, metabolism, excretion, and toxicity profiles were predicted through the pkCSM tool. Among the tested compounds, C-64 emerged as the most promising lead candidate, showing optimum binding affinity, compliance with Lipinski’s and Veber’s rules, and no predicted hepatotoxicity, cardiotoxicity, or mutagenicity. Moreover, C-64 displayed a high LD50 value, suggesting low toxicity, and the lowest total clearance, indicating prolonged retention. It also aligned well with key physicochemical parameters in the bioavailability radar and was positioned in the white region of the BOILED-Egg model, suggesting efficient gastrointestinal absorption. These findings position C-64 as a promising candidate for further optimization and preclinical development in cancer therapy.

1 August 2025 in Russian Journal of General Chemistry
Verified
Journal Article
Closed access
PDF file
DWD. Wanode
D. Wanode
DND. Nandurkar
D. Nandurkar
PKP. Khedekar
P. Khedekar
In this study, we present comprehensive work on synthesis, and anticancer evaluation of a new series of benzothiazole-pyrazole hybrids. The structures of the synthesized compounds were confirmed using a comprehensive suite of analytical techniques, including 1H, 13C NMR, FT-IR, and HRMS. Among the series, the hybrid compound featuring a para-fluorophenyl substituent on the pyrazole ring exhibited notable in vitro anticancer activity compared to standard 5-fluorouracil against the MCF-7 cell line. To support the experimental findings, in silico studies were performed using physics-based approaches such as AutoDock Vina, molecular dynamics (MD) simulations, and MM-GBSA calculations. These studies revealed strong binding affinity of the compound toward the target protein (PDB ID: 4AGC), with key interactions involving amino acid residues ALA113A, ILE120A, LEU121A, ILE124A, LEU201A, and ILE226A. Overall, this compound emerges as a promising lead candidate for further development in anticancer drug discovery.

4 October 2025 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
DWDeepali Wanode
Deepali Wanode
DNDeweshri Nandurkar
Deweshri Nandurkar
KBKumud Bhendarkar
Kumud Bhendarkar
TKTahmina Khan
Tahmina Khan
PKPramod Khedekar
Pramod Khedekar
Background: Green synthesis is crucial in organic chemistry because many industrial processes involve toxic chemicals and solvents that can significantly damage the environment. Green Chemistry wants to make synthetic procedures more effective and employ fewer harmful materials, reduce the number of steps in the synthetic routes, use fewer solvents and create as little waste as reasonably possible. In such way chemical synthesis will play a crucial role in advancing sustainable development. Methodology: Using a modified domestic microwave oven, a mixture of the corresponding chalcone and thiosemicarbazide was used to create 3,5- disubstituted-4,5-dihydropyrazole-1-carbothiamide. Synthesized compounds were characterised by using TLC and spectral data like FTIR, 1H-NMR and Mass spectra and evaluated for antimicrobial activity. Molecular docking was carried out by using AutoDock Vina 1.5.7 software against S. aureus biotin protein ligase (PDB ID: 3V7R). SWISSADME and pkCSM database were used for an investigation of their ADMET properties. Result and Discussion: The preparation of 4,5-dihydropyrazole derivatives with excellent yields was achieved by the green chemistry method of microwave-assisted technique. All the synthesised compounds revealed good antimicrobial activity against the pathogenic bacteria and fungi. Among all, compounds IIb and IIj exhibited good activity against E. coli and compound IIb, IIi and IIj was active against S. aureus whereas compound IId and IIj revealed promising activity against A. niger. In silico study demonstrated good docking score, excellent intestinal absorption, blood-brain barrier (BBB) permeability and complied with the Rule of Five. Toxicity testing revealed that none of the compounds caused cardiotoxicity, hepatotoxicity, AMES toxicity or skin sensitization as per the results predicted on the basis of ADMET study. Conclusion: The results indicate that compound IIj showing good activity against E. Coli, S. aureus and A. niger could be lead compound for the development of antimicrobial agents.